LeClaire Institute

Module 3 · Telomeres and Replicative Senescence

Telomeres, the repeated DNA at chromosome ends, and the limit on how many times many human cells can divide. The history runs from Hayflick to telomerase. The chart uses only published lengths. The argument separates what those papers agree on from the cancer tradeoff, the weak link to calendar age, and the fact that senescence has other causes. The figure is on the left and the lesson script on the right. The approximate Hayflick counts are a 2024 summary of the 1961 and 1965 papers. Every other number is taken from the paper named beside it.

Figures12345
1
Figure 1

Where the idea came from

A finite number of divisions, an end that is hard to copy, and an enzyme that adds the end back.

Finite division. Normal human diploid cells stop dividing after a limited time in culture. Hayflick and Moorhead, 1961, and Hayflick, 1965.

An unfinished end. DNA copying does not finish the extreme 3′ end of a linear chromosome. Olovnikov, 1973. Watson, 1972, is the independent statement.

Adding the end back. Telomerase. Greider and Blackburn, 1985, in Tetrahymena. Bodnar and colleagues, 1998, in normal human cells.

Telomeres limit how many times many human cells can divide. They do not, by themselves, set how long a species lives.

  1. 1961
    Finite divisionHayflick and Moorhead, Experimental Cell Research. Diploid cell strains stop. Cell lines do not. Serrano, npj Aging, 2024, summarizing that paper: 25 independent fetal isolates degenerated after approximately 50 subcultivations. That count is the obituary's, not a table reprinted here.
  2. 1965
    Donor ageHayflick, Experimental Cell Research. The same obituary, citing this paper: adult lung fibroblasts, mostly donors aged 58 to 87, approximately 20 doublings, against approximately 50 for fetal lung fibroblasts. Subcultivations and doublings are left in the words the obituary uses.
  3. 1972
    The endWatson, Nature New Biology, then Olovnikov, Journal of Theoretical Biology, 1973. Marginotomy is Olovnikov's name for the incomplete copying of the end. Watson's paper is Origin of Concatemeric T7 DNA. Wright and colleagues, 1997, cite both for the primer problem at the extreme 3′ end.
  4. 1985
    TelomeraseGreider and Blackburn, Cell. A Tetrahymena extract adds TTGGGG repeats. That is the ciliate repeat, not human TTAGGG. Heat and proteinase K destroy the activity.
  5. 1990
    ShorteningHarley, Futcher, and Greider, Nature. Telomeric DNA in human fibroblasts shortens with serial passage, and possibly with age. They say a causal role in senescence is not known. No base-pair rate in the abstract.
  6. 1998
    The testBodnar and colleagues, Science. The human telomerase catalytic subunit in retinal pigment epithelial cells and foreskin fibroblasts. Telomeres lengthened. The clones had already exceeded their normal lifespan by at least 20 doublings, with a normal karyotype. Cells in a dish.
Sources, with DOIs
  • Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25(3):585-621. 10.1016/0014-4827(61)90192-6
  • Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37(3):614-636. 10.1016/0014-4827(65)90211-9
  • Serrano M. Leonard Hayflick (1928-2024) – obituary. npj Aging. 2024;10(1). 10.1038/s41514-024-00174-0 The approximate subcultivation and doubling counts are this obituary's summary of the 1961 and 1965 papers.
  • Watson JD. Origin of Concatemeric T7 DNA. Nat New Biol. 1972;239(94):197-201. 10.1038/newbio239197a0 Crossref spells the title Concatemeric.
  • Olovnikov AM. A theory of marginotomy. J Theor Biol. 1973;41(1):181-190. 10.1016/0022-5193(73)90198-7
  • Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985;43(2):405-413. 10.1016/0092-8674(85)90170-9
  • Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345(6274):458-460. 10.1038/345458a0
  • Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 1997;11(21):2801-2809. 10.1101/gad.11.21.2801 The 40 to 200 base-pair range summarizes cultured human cells, Harley 1990 among the papers cited there.
  • Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279(5349):349-352. 10.1126/science.279.5349.349
  • Kipling D, Cooke HJ. Hypervariable ultra-long telomeres in mice. Nature. 1990;347(6291):400-402. 10.1038/347400a0
Hayflick and Moorhead, 1961, and Hayflick, 1965, are the finite-division papers. The approximate counts are Serrano, npj Aging, 2024, summarizing those papers, which have no Europe PMC abstract. Olovnikov, 1973, is marginotomy. Watson, 1972, is the independent end-replication paper. Greider and Blackburn, 1985, is Tetrahymena telomerase. Harley, Futcher, and Greider, 1990, is shortening in human fibroblasts, cause left open. Bodnar and colleagues, 1998, is the extension by at least 20 doublings.
2
Figure 2

How the end shortens

A schematic of one division, then the rates the papers actually print.

Schematic, not to scale. The bars are not base pairs. Vertebrate repeat TTAGGG, Kipling and Cooke, 1990. The rates underneath are the published numbers.

40 to 200 base pairs per division. Wright and colleagues, 1997, for normal diploid human cells in culture. A range across the studies they cite, Harley 1990 among them. Not the length of the RNA primer. Yeast, in the same paper, loses only a few base pairs per division without telomerase.
10 doublings per kilobase. Allsopp and colleagues, 1992. 31 donors, ages 0 to 93. Replicative capacity against starting telomere length, r = 0.76, P = 0.004. A regression across donors, not a conversion of the 40 to 200 range.
At least 20 extra doublings. Bodnar and colleagues, 1998, after the human catalytic subunit. Greider and Blackburn, 1985, found the activity in Tetrahymena. Harley, 1990, had left the cause open.
-15 base pairs per year in donors. The same Allsopp paper. Telomeric DNA against donor age, r = -0.43, P = 0.02. Doublings against age, -0.2 per year, r = -0.42, P = 0.02. They call both relatively weak. Sperm telomeres did not shorten with donor age.
Sources, with DOIs
  • Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 1997;11(21):2801-2809. 10.1101/gad.11.21.2801 The 40 to 200 base-pair range summarizes cultured human cells, Harley 1990 among the papers cited there.
  • Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345(6274):458-460. 10.1038/345458a0
  • Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89(21):10114-10118. 10.1073/pnas.89.21.10114
  • Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279(5349):349-352. 10.1126/science.279.5349.349
  • Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985;43(2):405-413. 10.1016/0092-8674(85)90170-9
  • Kipling D, Cooke HJ. Hypervariable ultra-long telomeres in mice. Nature. 1990;347(6291):400-402. 10.1038/347400a0
The drawing is not to scale. 40 to 200 base pairs per division is Wright and colleagues, 1997, a range across cultured-cell studies. Ten doublings per kilobase, and minus 15 base pairs per year, are Allsopp and colleagues, 1992. The extra doublings are Bodnar and colleagues, 1998.
3
Figure 3

Length, in published numbers

Human blood and mouse telomeres, only the ranges and averages the papers state.

Not one experiment. Human blood is an average from Kipling and Cooke, 1990. The mouse rows are Hemann and Greider, 2000. Mus spretus is a range they state from earlier work. The dashed row is a citation, not a new gel. Logarithmic axis.

102050100150Kilobases, logarithmic. A point is an average. A bar is a stated range.Mus spretus8 to 10Human bloodabout 10P. leucopusabout 12CAST/Ei18 to 20FVB/NJ30 to 120Established inbred mice30 to 150
Human blood, an averageShorter mouse telomeres, Hemann and GreiderFVB/NJ, their approximate rangeEstablished inbred mice, the range they cite from Kipling and Cooke
RowAs publishedSource
Mus spretus8 to 10 kb, stated from earlier papersHemann and Greider, 2000
Human bloodAverage, about 10 kbKipling and Cooke, 1990
P. leucopusAverage, about 12 kbHemann and Greider, 2000
CAST/EiAbout 18 to 20 kbHemann and Greider, 2000
FVB/NJAbout 30 to 120 kbHemann and Greider, 2000
Established inbred mice30 to 150 kb, citing Kipling and CookeHemann and Greider, 2000, citing Kipling and Cooke, 1990

Lifespan, from Hemann and Greider, printed beside length and not drawn as a second axis. C57BL/6J maximal lifespan 767 ± 147 days. CAST/Ei 681 ± 168 days. They say the difference was not significant. The paper does not say what the plus-or-minus is. Those lifespans are a personal communication in the paper. C57BL/6J telomeres were long and heterogeneous, so they have no kilobase midpoint on the chart. P. leucopus, about 12 kb, averages 5 to 7 years in Sacher and Hart, 1978, as cited there. The shortest telomeres they studied went with the longest lifespan.

Gomes and colleagues, 2011, a different comparison. Laboratory mice 25 to 150 kb, human germline 15 to 20 kb. Not the blood average of about 10 kb. Telomere length co-evolved with lifespan, P = 0.0032, no independent association with body size, P = 0.71. The direction is inverse. Ancestral placental length 18.6 kb. Probability telomerase was repressed, 0.998, against 0.002 that it was expressed. Only differences above 5 kb are treated as significant in that paper. Their species supplement is not replotted here.

Kipling and Cooke's up to 150 kb is an upper end of mouse fragments, not a mean. The chart does not show that telomeres are irrelevant. It shows that a longer telomere is not a longer species life. Late-generation telomerase knockout mice are the next figure.

Sources, with DOIs
  • Kipling D, Cooke HJ. Hypervariable ultra-long telomeres in mice. Nature. 1990;347(6291):400-402. 10.1038/347400a0
  • Hemann MT, Greider CW. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res. 2000;28(22):4474-4478. 10.1093/nar/28.22.4474 The two maximal lifespans are a personal communication printed in that paper. The 5 to 7 years for Peromyscus leucopus are cited there from Sacher and Hart, 1978.
  • Gomes NM, Ryder OA, Houck ML, et al. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination. Aging Cell. 2011;10(5):761-768. 10.1111/j.1474-9726.2011.00718.x
Points and bars are published averages and ranges. Human blood, about 10 kb, is Kipling and Cooke, 1990. Mouse rows are Hemann and Greider, 2000, except the dashed 30 to 150 kb row, which they cite from Kipling and Cooke. Lifespans in the note are the ones Hemann and Greider print. Gomes and colleagues, 2011, is the cross-mammal note, not a second set of bars.
4
Figure 4

Senescence, cancer, and the argument

The tradeoff, then what is broadly accepted and what is still contested.

One end, two consequences

Short. The end is read as a DNA break. d'Adda di Fagagna and colleagues, 2003: senescent fibroblasts show break markers, the chromosome ends contribute, and blocking the checkpoint kinases lets the cells enter S phase.
The brake. Telomerase is off in the normal somatic tissues Kim tested, and on in most of the cancers. Senescence stops a cell that would keep dividing on a bare end.
Long, or telomerase on. The division count is extended. The genetic studies put the cancer odds up, and some cardiovascular odds down.
Where telomerase is found. Kim and colleagues, 1994. Immortal cultures 98 of 100. Mortal cultures 0 of 22. Tumor biopsies 90 of 101, 12 tumor types. Normal somatic tissues 0 of 50. Ovary and testis positive. Fibroids negative. Mendelian randomization. Haycock and colleagues, 2017. 35 cancers and 48 non-neoplastic diseases. 420,081 cases and 1,093,105 controls. Odds ratio per standard deviation longer telomere. The table is the abstract's list.
DiseaseOdds ratio per SD longer95 percent interval
Glioma5.273.15 to 8.81
Serous low-malignant-potential ovarian cancer4.352.39 to 7.94
Lung adenocarcinoma3.192.40 to 4.22
Neuroblastoma2.981.92 to 4.62
Bladder cancer2.191.32 to 3.66
Melanoma1.871.55 to 2.26
Testicular cancer1.761.02 to 3.04
Kidney cancer1.551.08 to 2.23
Endometrial cancer1.311.07 to 1.61
Coronary heart disease0.780.67 to 0.90
Abdominal aortic aneurysm0.630.49 to 0.81
Celiac disease0.420.28 to 0.61
Interstitial lung disease0.090.05 to 0.15
Telomere syndromes. Heiss and colleagues, 1998, identified DKC1. Mitchell, Wood, and Collins, 1999: less telomerase RNA, less activity, shorter telomeres than matched cells. Vulliamy and colleagues, 2001: an 821-base-pair deletion removing the 3′ 74 bases of telomerase RNA, plus mutations in two other families. Armanios and Blackburn, 2012: marrow failure and lung fibrosis on the same short-telomere spectrum. Inherited disease, not the ordinary rate of aging.
Telomerase-deficient mice. Blasco and colleagues, 1997: viable for 6 generations, telomeres shorter by 4.8 ± 2.4 kb per generation. From generation 4, ends with no detectable repeats, and fusions. Cells could still immortalize and form tumors. Lee and colleagues, 1998: late-generation failure in testis and in blood-forming organs. Jaskelioff and colleagues, 2011: switching telomerase back on in that deficient line reversed degeneration in testis, spleen, intestine, and brain. Not ordinary wild-type aging. Senescent cells, a different entrance. Baker and colleagues, 2011, BubR1 progeroid mice: clearing p16-positive cells delayed changes in fat, muscle, and eye. Baker and colleagues, 2016, wild-type mice from 1 year of age: median lifespan up 27 percent on the mixed background and 24 percent in C57BL/6, sexes combined. By sex, 17 to 35 percent. Without a tumor, 24 to 42 percent. Maximum lifespan rose for the mixed sexes combined, P = 0.0295, and did not rise in C57BL/6. No benefit without the transgene. The mixed cohort's 9 percent fat diet shortens life relative to a 5 percent fat diet, which the paper says outright.

Broadly accepted

  • Normal human diploid cells in culture have a finite division count.
  • Telomeres shorten as human fibroblasts are passaged. Telomerase extended that count by at least 20 doublings in the Bodnar experiment, with a normal karyotype there.
  • In the tissues Kim tested, telomerase is on in most cancers and off in normal somatic tissue.
  • Inherited telomerase failure causes short-telomere disease, including dyskeratosis congenita.
  • Telomerase-deficient mice shorten their telomeres across generations. Turning the enzyme back on reversed several failures in that model.
  • Clearing p16-positive cells extended median lifespan in the 2016 wild-type mice, with the limits in the box above.
  • Telomere attrition is a hallmark in López-Otín and colleagues, 2013, and remains one in the 2023 list of twelve.

Contested, or a different mechanism

  • Weak as a clock of age. Allsopp: r = -0.43 against donor age, -15 base pairs per year. Müezzinler and colleagues: 124 cross-sectional studies, r = -0.338 for absolute length, 24.7 base pairs per year from the study means, and 32.2 to 45.5 in the few longitudinal studies. Martin-Ruiz and colleagues: rankings correlate 0.63 to 0.99, but absolute lengths do not travel between laboratories. Quantitative PCR varied by more than 20 percent between laboratories. Cawthon and colleagues: 143 people over 60, an association, 3.18-fold for heart-disease death and 8.54-fold for infection, the second interval 1.52 to 47.9.
  • Mice with long telomeres do not live long human lives, and within mice the short-telomere strains were not the short-lived ones. Across mammals, Gomes and colleagues found shorter telomeres with longer lifespan.
  • The cancer tradeoff. Haycock and colleagues: longer telomeres, higher odds of several cancers, lower odds of coronary heart disease. Keeping the end long is not free.
  • Senescence has other entrances. Serrano and colleagues, 1997: oncogenic ras provokes a senescence-like arrest in primary cells. Baker's mice were not telomerase knockouts. Still open: how much of ordinary human aging is the division limit, how much is other damage, and how much of the mortality association is cause. The rescue and the extra doublings were in a deficient mouse and in a dish.
Sources, with DOIs
  • d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003;426(6963):194-198. 10.1038/nature02118
  • Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266(5193):2011-2015. 10.1126/science.7605428
  • Haycock PC, Burgess S, Nounu A, et al. Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study. JAMA Oncol. 2017;3(5):636-651. 10.1001/jamaoncol.2016.5945
  • Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361(9355):393-395. 10.1016/S0140-6736(03)12384-7 The heart-disease interval is 1.36 to 7.45. PubMed prints the lower bound across a line break.
  • Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19(1):32-38. 10.1038/ng0598-32
  • Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402(6761):551-555. 10.1038/990141
  • Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413(6854):432-435. 10.1038/35096585
  • Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet. 2012;13(10):693-704. 10.1038/nrg3246
  • Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91(1):25-34. 10.1016/S0092-8674(01)80006-4
  • Lee HW, Blasco MA, Gottlieb GJ, Horner JW 2nd, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature. 1998;392(6676):569-574. 10.1038/33345
  • Jaskelioff M, Muller FL, Paik JH, et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 2011;469(7328):102-106. 10.1038/nature09603
  • Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479(7372):232-236. 10.1038/nature10600
  • Baker DJ, Childs BG, Durik M, et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature. 2016;530(7589):184-189. 10.1038/nature16932
  • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88(5):593-602. 10.1016/S0092-8674(00)81902-9
  • Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89(21):10114-10118. 10.1073/pnas.89.21.10114
  • Müezzinler A, Zaineddin AK, Brenner H. A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev. 2013;12(2):509-519. 10.1016/j.arr.2013.01.003
  • Martin-Ruiz CM, Baird D, Roger L, et al. Reproducibility of telomere length assessment: an international collaborative study. Int J Epidemiol. 2015;44(5):1673-1683. 10.1093/ije/dyu191
  • Hemann MT, Greider CW. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res. 2000;28(22):4474-4478. 10.1093/nar/28.22.4474 The two maximal lifespans are a personal communication printed in that paper. The 5 to 7 years for Peromyscus leucopus are cited there from Sacher and Hart, 1978.
  • Gomes NM, Ryder OA, Houck ML, et al. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination. Aging Cell. 2011;10(5):761-768. 10.1111/j.1474-9726.2011.00718.x
  • López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-1217. 10.1016/j.cell.2013.05.039
  • López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243-278. 10.1016/j.cell.2022.11.001
The fork is the senescence and cancer tradeoff. Counts are Kim and colleagues, 1994, and Haycock and colleagues, 2017. Syndromes are Heiss 1998, Mitchell 1999, Vulliamy 2001, and Armanios and Blackburn 2012. Mouse telomerase is Blasco 1997, Lee 1998, and Jaskelioff 2011. Clearance of p16-positive cells is Baker 2011 and 2016. The two columns separate what those papers support from what they dispute. The age correlations are Allsopp 1992, Müezzinler 2013, Martin-Ruiz 2015, and Cawthon 2003. Ras senescence is Serrano and colleagues, 1997.
5
Figure 5

From the literature

Reading-room pages on measuring telomeres and on senescence. Only what those pages say.

These cards open pages in Peer-Reviewed Literature, part of this course. Each line is only what that page says.

Links open the existing reading-room pages. Nothing is added beyond what those pages say.

Quiz

Tap a question to see the answer

1. What did Hayflick and Moorhead show in 1961?

That normal human diploid cell strains stop dividing in culture, unlike immortal cell lines. The approximate 50 subcultivations is Serrano's 2024 summary of that paper, not a table reprinted in this lesson (Figure 1).

2. How is Olovnikov's marginotomy different from telomerase?

Marginotomy is the incomplete copying of a chromosome end. Telomerase is the enzyme that adds repeats back. Greider and Blackburn, 1985, found that activity in Tetrahymena, adding TTGGGG, not human TTAGGG (Figure 1).

3. What did Harley, Futcher, and Greider show, and what did they leave open?

Telomeres shorten as human fibroblasts are passaged. They said it was not known whether that loss causes senescence (Figure 1).

4. What did Bodnar and colleagues test?

Putting the human telomerase catalytic subunit into normal human cells lengthened telomeres and let the cultures pass their usual limit by at least 20 doublings, with a normal karyotype in that paper. It was cells in a dish (Figures 1 and 2).

5. Why are 40 to 200 base pairs and 10 doublings per kilobase not the same number?

40 to 200 is a range of loss per division in cultured human cells, from Wright and colleagues, 1997. Ten doublings per kilobase is Allsopp's regression of remaining divisions on starting length, r = 0.76 (Figure 2).

6. What does the species chart show about mice?

Laboratory mice can have very long telomeres. CAST/Ei, about 18 to 20 kb, and C57BL/6J, with long telomeres, did not differ significantly in the maximal lifespans Hemann and Greider report. Gomes and colleagues found shorter telomeres with longer mammal lifespans (Figure 3).

7. What is the cancer side of a long telomere?

Kim and colleagues found telomerase in 90 of 101 tumor biopsies and in none of 50 normal somatic tissues. Haycock and colleagues found that genetically longer telomeres raise the odds of several cancers, including glioma, and lower the odds of coronary heart disease (Figure 4).

8. What is dyskeratosis congenita doing on this figure?

It is an inherited short-telomere disease. DKC1, telomerase RNA, and short telomeres in patients' cells show that telomere failure can cause proliferative disease. It is not a measurement of ordinary aging (Figure 4).

9. What did Jaskelioff and colleagues reverse, and in which mice?

Tissue degeneration, including in the brain, after telomerase was switched back on. The mice were late-generation telomerase-deficient mice, not ordinary old wild-type mice (Figure 4).

10. Why is telomere length still contested as a clock of human aging?

The correlation with age is weak, laboratories do not agree on absolute length, mice with long telomeres are not long-lived for that reason, and senescence is also triggered by oncogenic ras. Mortality findings such as Cawthon's are associations (Figure 4).

11. What do the reading-room pages not show?

They do not show that a telomere assay, a nuclear fluctuation, or an NAD precursor produced the historical rise in population life expectancy. The measurement paper is a preprint about a method. The heart result is old male mice (Figure 5).